Based on the limited information visible, this appears to be a company with regional operations in the UK, Germany, and France. More details needed for a complete description.

Mast Group Ltd

Mast Group

Based on the landing page, this appears to be a company with regional operations in the UK, Germany, and France. More details needed to provide a complete description.

Mast Group Ltd | 1,845 followers on LinkedIn. IVD solutions through partnership | Mast Group Ltd is a UK based leading independent European manufacturer and supplier of clinical diagnostic products.

Established in Liverpool in 1957, Mast Group has grown into a multinational company exporting globally. The corporate headquarters Mast Group Ltd are based in Bootle and has subsidiary companies in Reinfeld (Mast Diagnostica GmbH) and Amiens, France (Mast Diagnostic).

Chartered Engineer Specialising in Embedded Low-Level Software and Drivers

Graham Finney

Microbiologist

Susanne Chapman

Rebecca Booth

R&D Scientist at Mast Group Ltd

Kiran Mann

🌍 Hello from Istanbul! We’re excited to be exhibiting at the 33rd International Congress of Antimicrobial Chemotherapy (ICC)! Now in full swing and running until 6th November, the conference has already sparked invaluable discussions within the global infectious disease and clinical microbiology community. If you’re attending, connect with our experts Susan Thomson and John Struthers who are ready to showcase Mast Group’s latest advancements in antimicrobial susceptibility testing and innovative solutions for diagnosing antimicrobial resistance (AMR). #ICC2024 #AMR #AntimicrobialChemotherapy #AntimicrobialResistance #MastGroup #Diagnostics

📊 Antimicrobial Resistance: Tackling Inequalities in Healthcare The UK Health Security Agency describes its current work on inequalities relating to antimicrobial resistance in an important article published by the Royal College of Pathologists. The article highlights how Antimicrobial Resistance (AMR) disproportionately affects underserved communities. Bridging these healthcare gaps is essential in the fight against AMR. The authors advocate for a multi-faceted approach to ensure that all populations benefit from advancements in diagnostics and treatments. It's a must-read for anyone seeking to improving healthcare equity and combating AMR. At Mast Group, we are committed to developing and delivering high-quality AMR diagnostic solutions, helping clinicians make informed treatment decisions and improving patient outcomes worldwide. Learn more about our efforts at www.mast-group.com and discover the article here: https://lnkd.in/e7r-EWRj #AMR #HealthInequalities #RCPath #Antimicrobialresistance #PublicHealth

🚨 Just Days Away! Visit Mast Group at ICC 2024 in Istanbul 🚨 The 33rd International Congress of Antimicrobial Chemotherapy (ICC) in Istanbul is almost here! Visit our booth from November 3-6, where we’ll be featuring our leading AST and AMR diagnostic products including products such as MAST® CARBA PacE, MASTDISCS® and the MAST® DISCMASTER 8-place dispenser. 🔵MAST® CARBA PacE is a colorimetric test for rapid carbapenemase detection in less than 10 minutes in Pseudomonas spp., Acinetobacter spp. and Enterobacterales. 🔵The 8-place MAST® DISCMASTER delivers reliable and user-friendly dispensing of AST, ID, and combination discs from our MASTDISCS® range. 🔗 Learn more about MASTDISCS here: https://loom.ly/3gvajFs #ICC2024 #MastGroup #AMR #AntimicrobialStewardship #MASTDISCS #Diagnostics

We are excited to share that Mast Group has been selected for the Innovate UK Global Business Innovation Programme (GBIP) focused on Antimicrobial Resistance (AMR) in Sweden! The programme fosters innovation and collaboration between UK companies and Swedish partners. As pioneers in antibiotic susceptibility testing and diagnostic solutions, we are well positioned to contribute to the programme's goals, which align with our core mission of advancing solutions to combat AMR. The GBIP includes a six-day innovation tour of Sweden, a recognised leader in the global fight against AMR, with a robust national strategy and ongoing efforts to raise awareness, improve antibiotic stewardship, and promote innovative solutions. ▶️To learn more about Mast Group, visit https://loom.ly/Bks6UOQ #AMR #Innovation #Collaboration #GlobalBusiness #MastGroup #InnovateUK #Diagnostics #Sweden

New MASTDISCS®—AZA50C, RZF5C, and SUD20C - target critical pathogens, providing essential support for accurate antimicrobial susceptibility testing: ✅ RZF5C (Rezafungin 5 µg): Effective against candidemia, a major cause of bloodstream infections. https://loom.ly/u681wAY ✅ SUD20C (Sulbactam 10 µg/ Durlobactam 10 µg): Targets Acinetobacter baumannii, a WHO critical priority pathogen. https://loom.ly/kkqatfE ✅ AZA50C (Aztreonam 30 µg/ Avibactam 20 µg): Designed for complicated intra-abdominal and urinary tract infections caused by resistant gram-negative organisms. https://loom.ly/6ua6Q7g These new MASTDISCS® represent the latest developments in antimicrobial susceptibility testing and support optimal treatment decisions in the fight against antimicrobial resistance (AMR). AZA50C, RZF5C, and SUD20C are approved for use in UKCA territories only: England, Wales and Scotland. 📍 For local territory availability and more information, contact your Mast Group representative. ✉️For sales enquiries, please contact us: sales@mast-group.com #AST #antimicrobialsusceptibility #MastGroup #antimicrobialresistance #diagnostics

📢 Join Mast Group at the 33rd International Congress of Antimicrobial Chemotherapy (ICC) in Istanbul! We are excited to announce that Mast Group will be exhibiting at the 33rd International Congress of Antimicrobial Chemotherapy (ICC) in Istanbul, Turkey, next month. As leaders in antimicrobial susceptibility testing and AMR diagnostics, we will be showcasing our latest innovations in the global fight against antimicrobial resistance. This event will gather scientists, healthcare professionals, and industry experts to discuss crucial issues in antimicrobial chemotherapy and develop strategies to combat AMR. 🔬 What to expect at our booth: ☑️Diagnostics that enhance antimicrobial stewardship ☑️Pharma solutions to support the development of novel antimicrobials ☑️Insights into how diagnostics are key in the global fight against AMR We are looking forward to meeting AMR experts, sharing our expertise, and exploring new partnerships. 📍 Save the Date: November 3-6, 2024 Come and meet Mast Group to discover how we can collaborate to secure the future of healthcare! #ICC2024 #AMR #AntimicrobialChemotherapy #AntimicrobialResistance #MastGroup #Diagnostics

Celebrating 20 years of a strong partnership with Fort Richard Laboratories! A special mention to our very own Susan Thomson, featured here with Denise Burton, during her visit to FRL. Together, we're proud to continue delivering cutting-edge diagnostic microbiology solutions. Here's to many more successful years ahead! #FRL #MAST Denise Burton Susan Thomson

🌍 Tackling Antimicrobial Resistance: Professor Dame Sally Davies calls for urgent global action At Mast Group, we are proud to support the fight against antimicrobial resistance (AMR) and to contribute to global efforts in antimicrobial stewardship. In her interview below, Professor Dame Sally Davies, the UK's AMR Special Envoy, highlighted the growing threat AMR poses—potentially surpassing climate change in its danger to humanity and modern medicine. In her recent remarks, she called for decisive action at the upcoming United Nations high-level meeting on AMR, outlining key areas of focus: 🔵Prevention through Hygiene: Ensuring access to clean water and sanitation worldwide to reduce the spread of infections. 🔵Responsible Use of Antibiotics: Adhering to WHO guidelines for antibiotic use and phasing out the use of critical antibiotics in agriculture. 🔵Securing the Food Chain: Ensuring safe practices in food production to prevent the escalation of AMR. Professor Davies has praised the UK's progress in promoting responsible antibiotic use in healthcare. However, she warns that if we fail to contain AMR and develop new antibiotics, infections could soon claim more lives than cancer. At Mast Group, we are committed to advancing antimicrobial stewardship through innovative diagnostics and solutions, supporting these global efforts to safeguard the future of medicine. Let’s work together to stop AMR in its tracks. 🌍🛑 ▶️Watch the interview here: https://loom.ly/hrPdOQo #AMR #AntimicrobialResistance #AntimicrobialStewardship #GlobalHealth #AntibioticResistance

🔬 MAST ISOPLEX® VTEC Kit 🔬 We are thrilled to share the latest breakthrough in rapid diagnostics from Mast Group – the MAST ISOPLEX® VTEC Kit! This cutting-edge multiplex LAMP assay offers simultaneous detection of Shiga toxin/verotoxin 1 and 2 (stx1/vt1 and stx2/vt2) genes in verotoxigenic E. coli (VTEC) isolates. Key Highlights: 🔵Fast and Reliable: Results in under 10 minutes for high-analyte samples. 🔵High Sensitivity & Specificity: 96% sensitivity and 100% specificity. 🔵Multiplex in One Reaction: Simultaneous detection of multiple targets without post-amplification steps. 🔵Long-Term Stability: Lyophilized format allows for 2-year storage (at 2°C to 8°C) and ambient temperature shipping. Rapid detection of VTEC is crucial for public health as it enables timely intervention to prevent severe complications, control outbreaks, and reduce the spread of this potentially life-threatening infection. The MAST ISOPLEX® VTEC Kit opens up new possibilities for rapid, cost-effective, and point-of-care diagnostics in both clinical and low-resource settings. Read the MAST ISOPLEX® VTEC Kit publication in the International Journal of Molecular Sciences: https://loom.ly/Nz8ItJ8 Learn more about MAST ISOPLEX® VTEC Kit at the Mast Group web site: https://loom.ly/xUoptmk #RapidDiagnostics #Innovation #VTEC #LAMPassay #Biotechnology #MastGroup #POCT #RapidTesting

We have an exciting opportunity for an Engineering Technician to join our team! Key Responsibilities: 🔧 Ensure that products are assembled in a cost effective and timely manner 🔧 Manage stock, assembly, and incoming goods 🔧 Perform technical inspections (GIQC) 🔧 Prioritise workload against deliverables and manage timelines 🔧 Manage goods in, goods out, stock and inventory in an auditable fashion The person: 👤 2+ years relevant experience 👤 Strong attention to detail 👤 Experience in assembly and reading engineering drawings 👤 Skilled in using a range of manual and electronic tools 👤 Computer literate 👤 A proactive, flexible team player with the ability to work independently 📍 Mast Group Locations: Bootle & Daresbury 📧 For further information and to apply, visit our website: https://loom.ly/vVOu3VA #EngineeringJobs #JoinOurTeam #MedicalDiagnostics #Hiring #MastGroup

COM:MAST-GROUP

Mast Group

name

homepage url

country

linkedin url

crunchbase url

employee count

sector

industry

monthly webtraffic

monthly webtraffic growth

Description

competitor of

Metrics